Table 1 Demographic and clinical characteristics of human subjects
Controls (n = 48) | T1DM (n = 29) | |
|---|---|---|
Age (years) | 32.3 ± 1.4 | 32.5 ± 1.7 |
SBP (mmHg) | 116.2 ± 1.8 | 136.0 ± 1.8* |
DBP (mmHg) | 73.2 ± 1.1 | 74.2 ± 1.3 |
Glucose (mg/dL) | 87.7 ± 1.6 | 160.3 ± 13.6*** |
HbA1c (%) | 5.3 ± 0.1 | 7.6 ± 0.2*** |
BMI | 23.3 ± 0.6 | 25.5 ± 0.5 |
Total cholesterol (mg/dL) | 182.2 ± 4.1 | 175.7 ± 5.4 |
HDL-C (mg/dL) | 61.46 ± 1.7 | 56.8 ± 1.5 |
LDL-C (mg/dL) | 116.12 ± 3.2 | 114.3 ± 4.5 |
apoB (mg/dL) | 84.88 ± 2.7 | 84.77 ± 3.4 |
Triglycerides (mg/dL) | 75.9 ± 4.3 | 67.7 ± 4.7 |
CC-IMT (mm) | 0.41 ± 0.01 | 0.46 ± 0.01** |
% of lipid-lowering therapies (statins) | 0 | 19.35*** |